Defunct Company
Total Trials
29
As Lead Sponsor
25
As Collaborator
4
Total Enrollment
2,592
NCT00105976
Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2005
Completion: Not specified
NCT00147329
Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis
Start: Sep 30, 2005
Completion: Jul 31, 2006
NCT00444743
Phase 2 Study of MM-093 to Treat Patients With Uveitis
Start: Feb 28, 2007
NCT00458146
A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis
NCT00734305
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Phase: Phase 1
Start: Jul 31, 2008
Completion: Sep 30, 2013
NCT00911898
A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers
Start: Jun 30, 2009
Completion: Mar 31, 2012
NCT00994123
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Phase: Phase 1/2
Start: Feb 28, 2010
Completion: Jun 30, 2015
NCT01097460
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Start: Apr 30, 2010
Completion: Jul 31, 2013
NCT01151046
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Start: Jun 30, 2010
Completion: Sep 30, 2014
NCT01209195
A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Start: Oct 31, 2010
Completion: Jul 31, 2014
NCT01304784
A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer
Start: Jan 31, 2011
Completion: Jun 30, 2014
NCT01304797
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Start: Mar 31, 2011
Completion: Jan 31, 2017
NCT01421472
A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
Start: Aug 31, 2011
NCT01447225
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Start: Oct 31, 2011
Completion: Jan 31, 2014
NCT01447706
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
NCT01451632
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
NCT01494506
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
Phase: Phase 3
Start: Nov 30, 2011
Completion: Oct 31, 2015
NCT01436565
A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers
Role: Collaborator
Completion: May 31, 2014
NCT01520389
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Start: Jan 31, 2012
Completion: Jan 31, 2016
NCT01733004
A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Start: Nov 30, 2012
NCT01774851
A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
Start: Jan 31, 2013
Completion: Dec 31, 2015
NCT02213744
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
Phase: Phase 2/3
Start: Jul 31, 2014
Completion: Jun 30, 2017
NCT02387216
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Start: Feb 1, 2015
Completion: Jan 2, 2019
NCT02399137
A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
Start: May 31, 2015
Completion: Aug 31, 2018
NCT02538627
Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
Start: Aug 31, 2015
Completion: Oct 5, 2016
NCT02640365
A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer
Start: Nov 18, 2015
Completion: Dec 7, 2016
NCT02785068
Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer
Start: Jul 31, 2016
Completion: Oct 31, 2018
NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors
Start: Feb 22, 2017
Completion: Dec 31, 2018
NCT03119064
BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
Start: Nov 30, 2017
Completion: Oct 8, 2021